From: Fulminant hepatic failure in a patient testing re-positive for SARS-CoV-2: a case report
Laboratory investigation | Result | Reference range | |
---|---|---|---|
Hematological profile | Hemoglobin (g/dL) | 11.4 | 13.0–18.0 |
White blood cell (1000/μL) | 9.8 | 4.0–11.0 | |
Platelet (1000/μL) | 448 | 140–450 | |
Neutrophils (%) | 75.4 | 40–60 | |
Lymphocytes (%) | 11.0 | 20–40 | |
Hepatic profile | Total bilirubin (mg/dL) | 1.3 | 0.2–1.2 |
Albumin (g/dL) | 4.0 | 3.4–5.0 | |
Alkaline phosphatase (U/L) | 150 | 46–116 | |
γ-Glutamyltransferase (U/L) | 49 | 15–85 | |
Alanine transferase (U/L) | 2,411 | 14–63 | |
Aspartate transferase (U/L) | 2,466 | 15–37 | |
Coagulation profile | Prothrombin time (s) | >120 | 12.9–15.9 |
Partial thromboplastin time (s) | 120 | 25.6–42.3 | |
International normalized ratio | >15.8 | 0.8–1.1 | |
Inflammatory profile | C-Reactive protein (mg/dL) | <0.10 | 0.10–0.50 |
Lactic acid (mmol/L) | 19.7 | 0.5–2.2 | |
Ferritin (ng/ml) | 165.2 | 4.6–204.0 | |
Serology profile | Hepatitis A IgM antibody | Negative | Negative |
Hepatitis B core antibody | Negative | Negative | |
Hepatitis B surface antibody | Negative | Negative | |
Hepatitis C virus antibody | Negative | Negative | |
Ebstein-Barr virus IgM antibody | Negative | Negative | |
Cytomegalovirus IgM antibody | Negative | Negative | |
Human immunodeficiency virus antibody | Negative | Negative | |
Autoimmune profile | Antimitochondrial antibody | Negative | Negative |
Antinuclear antibody | Negative | Negative | |
Anti-liver/kidney microsomal antibody | Negative | Negative | |
Anti-smooth-muscle antibody | Negative | Negative | |
Toxicology profile | Acetaminophen | Negative | Negative |
Tetrahydrocannabinol | Negative | Negative | |
Benzodiazepines | Negative | Negative |